Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 7 Breast Neoplasms 3 Triple Negative Breast Neoplasms 2 Pancreatic Neoplasms 2 Ovarian Neoplasms 2 Neoplastic Syndromes, Hereditary 2 Colorectal Neoplasms, Hereditary Nonpolyposis 2 Sarcoma 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Melanoma 1 Lymphoproliferative Disorders 1 Kidney Neoplasms 1 Hereditary Breast and Ovarian Cancer Syndrome 1 Hematologic Neoplasms 1 Endometrial Neoplasms 1 Cytopenia 1 Congenital Bone Marrow Failure Syndromes 1 Colorectal Neoplasms 1 Carcinoma, Intraductal, Noninfiltrating 1 Cancer Risk Syndrome 1 Breast Neoplasms, Male 1 Bone Marrow Failure Disorders 1

Interventions

pembrolizumab 105 Specimen Handling 55 Magnetic Resonance Spectroscopy 48 Biopsy 47 Nivolumab 40 Paclitaxel 35 Gemcitabine 30 Radiosurgery 29 Carboplatin 28 Irinotecan 22 Ipilimumab 22 Cyclophosphamide 22 Cisplatin 22 trastuzumab deruxtecan 21 Leucovorin 19 Capecitabine 19 Fluorouracil 18 Cetuximab 18 Bevacizumab 18 130-nm albumin-bound paclitaxel 18 Pemetrexed 17 Fulvestrant 17 Drug Therapy 16 Docetaxel 16 Taxes 15 Oxaliplatin 15 olaparib 14 abemaciclib 14 Radiotherapy 14 palbociclib 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasm Metastasis × Genetic Counseling × 1 year × Clear all

NCT03503097 2025-10-01

GENTleMEN

University of Washington

Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡